A focus on patients, families, and practices

ParaPRO is a specialty pharmaceutical company that was established in 2002 to discover and commercialize human clinical uses for the anti-parasitic spinosad compound through an agreement with Eli Lilly. Our strategy focuses on:

  • Innovating anti-parasitic formulations that eradicate infestations and minimize the disruption and economic burden on patients and families
  • Supporting the broader professional community with the most current insights, tools, and resources that educate and inform
  • Partnering with industry organizations from the National Association of School Nurses (NASN) to the American Academy of Family Physicians (AAFP) to bring about better outcomes for children and their families
We have and always will be entrepreneurially minded and accountable to our customers, passionate about advancing the quality of care for patients, and motivated to make a difference in the everyday lives of families across the country.